AA -antimycin A; IMM -inner mitochondrial membrane; mt-11S -mitochondrial-targeted 11S; H6 11S -Nterminal 6xHis tagged version of 11S; OMM -outer mitochondrial membrane; OVA -oligomycin, valinomycin and antimycin A (full depolarisation cocktail); MTS -mitochondrial targeting sequence, NanoBiT -NanoLuc Binary Technology; PAM -presequence-translocase-associated import-motor; pep86high-affinity version of NanoBiT small fragment; pep114 -small fragment of NanoBiT; PMF -proton motive force; TIM -translocase of the inner membrane; TOM -translocase of the outer membrane; 11Slarge fragment of the NanoBiT; Δ Ψ -membrane potential.
INTRODUCTION
A large proportion of proteins fulfil their function outside the cell, or in a subcellular compartment distinct from the cytosol. To get there, they must be sorted and then transported across the appropriate membranes; thus, protein translocation systems are ubiquitous and fundamental features of cellular compartmentalisation.
For example, bacteria target about 20% of their proteome to the Sec system for transport across or into the plasma membrane 1 , while nearly all mitochondrial proteins are produced in the cytosol for import through the Translocases of the Outer and Inner Membranes (TOM and TIM). In both of these cases, proteins are recognised by specific targeting sequences that are often cleaved upon completion of transport to liberate the mature protein.
Previously, protein translocation has been monitored in vitro by quantifying time courses of proteins transported into the interior of reconstituted proteoliposomes (PLs) or native membranes, e.g. bacterial inner membrane vesicles 2,3 (IMVs) or intact mitochondria 4, 5 In these experiments, successfully transported protein is typically characterised by resistance to proteolysis and detected by Western blotting or autoradiography.
These classical methods have been instrumental for the determination of the molecular components and basic properties of the various prokaryotic 6 and eukaryotic translocation apparatus 7, 8 . However, such assays are not suited to a more sophisticated analysis, due to lack of kinetic detail -they produce only discontinuous, endpoint measurements -and are labour intense, making them difficult to scale to high-throughput. Over the past two decades, various alternative methods have been proposed (Table S1 ), all of which have drawbacks. A highly sensitive, versatile and quantitative real-time assay has yet to be developed.
Recently, Dixon, et al. 9 developed a non-covalent complementation system based on a small, bright luciferase, to monitor protein-protein interactions -NanoBiT (short for NanoLuc Binary Technology). In this split-luciferase, the final β -strand of NanoLuc was cleaved to generate a large fragment of 18 kDa, referred to as 11S (trademark name LgBiT), and a small 1.3 kDa peptide chain of 11 amino acids, termed pep114 (trademark name SmBiT). The authors also developed a high-affinity variant of pep114, pep86 (trademark name HiBiT; picomolar range); here, we exploit the rapid, spontaneous interaction between 11S and pep86 as the basis for a protein translocation assay.
Using simple genetic tools, we targeted 11S to two model destination compartments: the yeast mitochondrial matrix and the Escherichia coli periplasm (Fig. 1) . The presence of lipid bilayers keeps the reporter segregated, ensuring that complementation is restricted to the destination cell compartment.
Substrates pre-proteins, i.e. proteins with their targeting sequence uncleaved, are then tagged with pep86 at their C-terminus. Upon translocation, the rise in local protein concentration leads to complementation of pep86 with internalised 11S, producing active luciferase activity and thus a readout for protein translocation (Fig. 1 ). Pep86 is small and native-like, so should eliminate artefacts caused by non-native tags such as fluorescent dyes, and have negligible effect on transport rates. The enzymatic amplification generated by NanoLuc, meanwhile, provides very high sensitivity measurements compared to conventional methods (Table   S1 ), allowing detailed quantitative analyses of translocation. We anticipate that the techniques and tools described here will readily be transferrable to many other membrane and non-membrane protein translocation systems.
RESULTS

In vitro continuous translocation assay of the bacterial Sec machinery
The bacterial Sec system is the principal mechanism for protein secretion across the bacterial plasma membrane, and a good starting point for assay development as its activity has been extensively studied.
Transport through the Sec machinery can be recapitulated in vitro using only a small number of purified components: PLs 6 or IMVs 10, 11 containing the SecYEG protein-channel membrane protein complex, the soluble motor ATPase SecA, a pre-secretory protein substrate with a cleavable N-terminal signal sequence and ATP as an energy source. In both cases, successful translocation results in internalisation of pre-protein, equivalent to translocation into the periplasm in vivo. When the reaction is complete, protease K is added to digest untranslocated pre-protein, while the vesicle protects the successfully translocated material.
Alternatively, samples can be taken from the reaction at various time points and quenched with ice-cold buffer containing protease K, to investigate the transport kinetics. Analysis is typically performed by SDS-PAGE followed by autoradiography (of radiolabelled substrates) or immunoblotting ( Fig. 2a ).
These assays do not enable an exploration beyond a simple analysis, so we set out to modify SecYEG PLs, IMVs and substrate pre-proteins such that they would be compatible with a split NanoLuc-based assay ( Fig.   1b ). For PLs, we included purified 6H 11S into the reconstitution mixture then removed excess protein by three rounds of centrifugation and resuspension in clean buffer. To ensure a high concentration of internalised 11S within IMVs, we produced a variant of 11S with an inner membrane lipid anchor sequence 12 . We then cotransformed the expression vectors harbouring 11S and SecYEG into E. coli and induced expression of both plasmids simultaneously. Pre-proteins were extended at the C-terminus by a GSG linker followed by pep86.
Reactions were initially set up with either PLs or IMVs saturated with SecA together with: an ATP regeneration system, Prionex -a biocompatible polymer used for protein stabilisation and to prevent 11S/preprotein-pep86 from adhering to surfaces, and the NanoLuc substrate furimazine. Luminescence measurements were then started to generate a baseline reading, followed by addition of the model pre-protein, proOmpA, fused to pep86 ( Figure 2b ).
The initial experiments were prone to a high, ATP-independent luminescence signal, presumably due to contaminating external 11S, remnants of the reconstitution or from burst vesicles. This problem was resolved by supplementing the mixture with an inactivated form of the pep86, 'dark' peptide 13 . This peptide differs from the pep86 sequence by a point mutation at a critical catalytic Arginine residue, which does not prevent high affinity binding to 11S, but prevents catalysis once bound. For ease of production, we synthesised a fusion of glutathione-S-transferase and the 'dark' peptide, which we named GST-dark. The inclusion of 40 µM GST-dark did indeed massively reduce, but did not completely obviate, the background signal contribution (Fig. 2b) . The remaining background signal could be fitted to either a single or double exponential function and subtracted from the data acquired after the addition of ATP (Fig. 2b) .
The high detail of the background-corrected transport traces is clear ( Fig. 2b ). To confirm that the data report on the kinetics of translocation rather than slow rate-limiting pep86-11S association, we performed further assays with PLs containing a range of 11S concentrations (Fig. S1 ). The results show that while the signal amplitude is proportional to the concentration of 11S -i.e. the reaction ends when 11S runs out -the shape of the curve is completely unaffected. Thus, rates extracted from the data do indeed reflect the rate of transport.
To demonstrate the versatility of the assay, we also linked the pep86 sequence to the C-terminus of a very different E. coli pre-protein -the soluble, positively charged and α -helical spheroplast protein Y (Spy), for comparison against the β-barrelled proOmpA. The translocation data for proSpy ( Fig. 2c , green trace) are qualitatively similar to those of proOmpA, demonstrating the broad compatibility of the assay. Importantly, removal of either the signal sequence or pep86 from proSpy, or SecA from the reaction mixture collapsed the signal. The omission of SecA from experiments conducted with IMVs retained residual activity (Fig 2c, blue trace), probably due to contamination by endogenous membrane associated SecA 14 .
Taken together, the results show that the luminescence signal is a bona fide measure of protein transport and suitable for a comprehensive kinetic analysis of the ATP and proton motive force (PMF) driven secretion process -to be described in forthcoming publications.
In vivo β -lactamase secretion assay
Next, we set out to design a split-NanoLuc-based system for measuring translocation through the bacterial translocon in vivo (Fig. 1c ). For this, we attached pep86 to the pre-secretory protein New Delhi Metallo-betalactamase 1 (NDM1) -a protein of great current interest due to its involvement in mediating antibiotic resistance in hospitals 15 . We also constructed an 11S variant with the N-terminal signal sequence of proOmpA (forming pro-11S), directing it to the periplasm. To reduce the background from newly synthesised pro-11S
that has yet to be secreted, GST-dark was expressed in the cytoplasm (Fig. S2 ). By comparing an E. coli strain with severe secretion defects 16 to its parent strain, we show that this system does indeed produce a secretiondependent luminescence signal (Fig. 2d ). This in vivo measure of secretion will be a powerful tool for understanding the native secretion process as well as for the development of new strategies for antibiotic discovery and against Anti-Microbial Resistance (AMR).
Real-time import assay in isolated yeast mitochondria
Over the past forty years, isolated mitochondrial fractions of S. cerevisiae have been used widely to study protein translocation in vitro. Since tools for genetic engineering of yeast are widespread and large quantities of the organism can be grown to yield considerable amounts of mitochondria, yeast mitochondria are a perfect candidate for applying split-NanoLuc to a eukaryotic protein translocation system ( Fig. 1a ).
Classical mitochondrial import assays employ autoradiography or western blotting ( Fig. 3a ) to detect transport. Similar to the bacterial setup, reaction aliquots representing time points were quenched by moving samples to ice followed by addition of a 'death' cocktail of oligomycin, valinomycin and antimycin A (OVA) and protease K, to respectively collapse the PMF and digest non-translocated precursors. Import is indicated by detection of the mature protein, i.e. after cleavage of the mitochondrial targeting sequence (MTS), by SDS-PAGE followed by immunoblotting. As shown in Fig. 3a , the data points are discrete with a time resolution on the order of minutes.
To develop the new transport assay, we targeted 11S to the mitochondrial matrix using the presequence of subunit F 1 α of the yeast ATP synthase (mt-11S). After mitochondrial isolation, samples were analysed by SDS-PAGE to confirm localisation of 11S to the matrix (Fig. S3a ). The mass of mt-11S is identical to that of purified H6 11S, suggesting efficient localisation to the matrix, where the MTS is removed. Under standard culture conditions, 1% galactose resulted in 1.34 ± 0.05 µM of mature 11S in mitochondria, assuming a standard matrix volume of 1.1 µL/mg of protein 17 and using pure H6 11S as a standard ( Fig. S3c ).
As an import substrate, we used the classical yeast import precursor cytochrome B2 (CytB2; YML054C) with its hydrophobic sorting domain removed (CytB2 Δ 43-65 ), causing it to localise to the matrix 18 . We found that standard in vitro import reactions conditions 4, 8, 19 required optimisation: but by lowering both the concentration of mitochondria and of furimazine, we were able to produce a strong, transport-dependent luminescence signal, which could be maintained for minutes ( Fig. S4 ).
A typical optimised import assay trace is shown in Fig. 3b . It comprises a baseline corresponding to the background produced by 11S alone (omitted from the graph) followed by a sigmoidal shape upon CytB2 Δ 43-65 -pep86 addition. No increase in signal was observed if the low-affinity tag pep114 was used, confirming that spontaneous complementation is necessary to report translocation ( Fig. 3b , purple trace). In a separate experiment, mitochondrial respiration was inhibited, and membrane potential (ΔΨ) dissipated by addition of the OVA 'death' cocktail ( Fig. 3b , green trace). Under these conditions, no rise in luminescence was observed upon addition of CytB2 Δ 43-65 -pep86, confirming that the signal reflects energy-dependent import. Note that background luminescence in the presence of OVA was significantly higher than the baseline (~12%) -albeit without the characteristic sigmoidal shape ( Fig.S5 ) -suggesting import-independent complementation is due to leakage of 11S from broken mitochondria.
To eliminate the possibility of mitochondrial poisons non-specifically interfering with the assay, we performed binding assays in the presence of low and high concentration of these drugs (Table S1 ). This was the case only for CCCP, which at 1 µM lowered the maximum amplitude to 40% if pre-incubated. Therefore, CCCP was not used from here onwards.
Next, we utilised the high-throughput character of the assay and monitored CytB2 Δ 43-65 -pep86 import over a range of concentrations. Attempts to carry out a similar titration assay using the conventional method have failed to deliver reliable results ( Fig. 3c ), due to the limited range of concentrations that can be practically measured (~24-120 nM). By contrast, the split-luciferase assay produces a dose-response curves of CytB2 Δ 43-65 -pep86 spanning two orders of magnitude (7-1000 nM), with sufficient data quality to extract kinetic parameters ( Fig. 3d) . To ensure the observed kinetics report on import, rather than complementation of the reporter, we performed binding experiments with CytB2 CytB2 Δ 43-65 -pep86 and 11S is much faster than the rate of translocation ( Fig. S6 ), we can be assured the signal provides a faithful measure of import.
The amplitude of import extracted from the dose-response curve of CytB2 Δ 43-65 -pep86 was fitted to an equation for specific binding, yielding a low dissociation constant (K d ) of 12.7 ± 1.4 nM. Furthermore, the import rates vary in a hyperbolic manner with respect to precursor concentration, suggesting a Michaelis-Menten relationship, shown in the linearized Hanes-Wolf plot (Fig. 3d ). This confirms that CytB2
import is limited by the number of import sites.
Exploring energy-dependency of the mitochondrial import system
Next, we explored the energy dependency of the mitochondrial import system, given that protein import is known to be ATP-and PMF-dependent. When mitochondria were energised with NADH in the absence of ATP, the addition of the mitochondrial respiration inhibitor antimycin A (AA) was able to inhibit CytB2 . Therefore, addition of ATP as part of an ATP regenerating system was able to restore import, suggesting that the reverse activity of ATP synthase generates sufficient Δ Ψ to drive CytB2 Δ 43-65 -pep86 import (Fig. 4b ). Interestingly, higher concentrations of AA in this setup caused additional inhibition of import (amplitude and rate), which we attributed to non-specific effects on mitochondrial physiology. Further evidence for the ATP synthase driving import in the presence of AA was obtained when matrix ATP influx was blocked by the adenine nucleotide translocase inhibitor carboxyatractyloside (CAT; Fig. 4c ) or ATP hydrolysis by the ATP synthase inhibited with oligomycin (Oligo; Fig. 4d ). In the first case, ATP uptake is blocked, and the effect is two-fold -no ATP is available to drive import or to generate PMF. In the latter case, ATP enters the matrix but cannot be used to generate PMF due to inhibition by oligomycin. Although both drugs (CAT and Oligo) lowered the amplitude of import in a dose-dependent manner, oligomycin had no effect on k app suggesting that Δ Ψ determines the extent of CytB2 Δ 43-65 accumulation.
Exploring the effect of small molecules on mitochondrial import
We used two small molecule inhibitors of the TIM23 pathway, identified by the Koehler Lab, to validate the assay: MB-12, also known as dequalinium 4 , and MB-10 5 . In accordance to previous reports 4 , we found that MB-12 causes a dose-dependent inhibition of CytB2 Δ 43-65 -pep86 import with an IC 50 5.05 ± 0.32 µM ( Fig.   5 ). The IC 50 of MB-10, meanwhile, was 373 ± 16.4 µM ( Fig. 5 ) -significantly higher than previous reported 5 .
Interestingly, both drugs showed a stronger inhibitory effect on translocation when the mitochondria were energised by the reverse activity of the ATP synthase, possibly reflecting non-specific effects. This effect was more pronounced for MB-12 (IC 50 = 0.437 ± 0.019 µM) than for MB-10 (IC 50 = 102 ± 6.9 µM).
Effect of signal sequence deletion
Finally, we evaluated the effect of removing the presequences from the import substrates, anticipating that the mature part alone would not import. However, because of the high sensitivity of our assay, we were able to observe that removal of the presequence 20 (CytB2 interesting new feature of the precursor targeting determinants: one that, along with many other facets of the import process, can now be dissected in detail by the application of this validated new and powerful tool.
DISCUSSION
To understand protein transport across membranes, it is vital to be able to measure it. Until now, such experiments have been difficult to perform and scale, and have yielded very little kinetic insight. The splitluciferase-based assay optimised and validated here solves these problems. Indeed, our success in adapting NanoBiT to different conditions, both in bacteria and mitochondria, suggests that it will be compatible with many other membrane and non-membrane bound protein translocation machines.
Attempts to develop real-time import assays have been made previously, e.g. by labelling pre-proteins with fluorescent dyes 21, 22 . These have provided some information on the mechanism of protein secretion by the bacterial Sec system, however, the risk of inefficient labelling represents possible competition for translocation by non-labelled protein, affecting overall kinetic analyses. And perhaps most importantly, fluorescent dyes are significantly different from amino acid side chains both in terms of size and composition -raising questions as to the physiological relevance of the measurements. The pep86 tag circumvents these problems: it can be cloned easily onto the C-terminus of a pre-protein, and as a short peptide it resembles exactly a native translocation substrate. Its relatively small footprint should not affect transport kinetics appreciably. Although we decided to place pep86 on the C-terminus of pre-proteins, the tag will bind with high affinity to 11S as long as it is available and not sterically hindered, which means it could also be placed in internal protein loops, as previously reported 23 .
Bipartite systems, such as the split-NanoLuc used in present work, have been used to evaluate protein translocation before [24] [25] [26] . Ensembled 27 or split-GFP 25 are limited by the fact that maturation of the chromophore (or that of any fluorescent protein) is a slow process, in the order of minutes 28 . This is much slower than protein translocation, and therefore would be rate limiting, precluding any kinetic assessment of the biological process, and probably explains why it has been only really used for low time-and spatialresolution in vivo analysis of protein localisation. Split-β-galactosidase systems, such as CAPT 24 or PathHunter 26 (trademark of DiscoverX) are closer to our split-NanoLuc-based assay in that both rely on inactive fragments to restore enzyme activity. However, while Wehrman, et al. 24 reported a tag of 46 aa in the CAPT system that spontaneously associates with a bigger fragment, the authors did not measure binding affinity, so the response time may be limited by the association of the fragments.
A possible disadvantage when using high 11S concentrations is fast depletion of its substrate Furimazine.
However, we lowered the amount of biological sample to avoid this problem while maintaining high sensitivity. It also suggests that in special cases where the amount of starting material for cell fractioning is an issue, such as mammalian cells, zebra fish, fruit flies or flat worms, our assay can be a practical tool to use.
The real-time assay showed a robust, reliable and high-dynamic range whenever it was challenged with standard controls for studying protein translocation. The signal readout, i.e. translocation was energydependent and signal-sequence specific and, it could be unambiguously inhibited with known inhibitors of the translocon. An important aspect of the system is its ability to distinguish nuances beyond the capabilities of the classical methods; either in terms of signal sequences or, to detect protein import in response to (patho)physiological energisation conditions. For example, to our knowledge it is the first time that protein import driven by the reversal of ATP synthase has been observed. In a cellular context, it means that respiration-impaired mitochondria can still efficiently import proteins as long as cytosolic ATP is available.
Contrarily to some recently developed high sensitivity methods [29] [30] [31] [32] for measuring translocation (Table S1) , the requirements for our new assays is a simple luminometer, and standard molecular cloning procedures.
Overall, this means that the real-time assay can be easily adopted by current or new laboratories working on protein translocation without the need of advanced knowledge on specific tools or techniques, while still providing high sensitivity and specificity.
The flexibility of the new assay show that it is not restricted to the systems presented here, but can be readily adapted to other frameworks, such as peroxisomes, chloroplasts, endoplasmic reticulum, nucleus or plasma membrane. Or even for monitoring protein translocation in non-membrane associated systems, such as to the interior of protein cages like GroEL or the proteasome.
Monitoring protein secretion through the plasma membrane using NanoBiT has already been described in mammalian cells 33 and in Gram-positive bacteria 34 . However, employing the same approach to Gram-negative bacteria is considerably challenging because the outer membrane in their cell envelope provides a low permeability barrier. Therefore, instead of exogenous addition of 11S we targeted it to the periplasm while coexpressing the 'dark' peptide in the cytosol. This approach is preferable to the use of low affinity tags/peptides 9, 24 because it ensures that spontaneous binding in the destination compartment is retained and paves the way to monitor β -lactamases secretion in vivo and in real-time. Thus, we believe the assay will prove to be valuable for both fundamental research in protein trafficking systems, as well as for high throughput drug screening.
MATERIAL AND METHODS
Reagents
All chemicals, such as antibiotics, inducers and mitochondrial poisons, were of the highest commercially available grade of purity and were purchased from Sigma-Aldrich. Aqueous solutions were prepared in ultrapure (type I) water (Milli-Q Biocel A10 with pre-treatment via Elix 5, Millipore, Billerica, MA, USA).
For non-aqueous solutions, ethanol (99.5%) or dimetylsulfoxide (DMSO), both from Sigma-Aldrich, were used as solvent.
Culture conditions
Bacterial strains were cultured in LB or 2XYT for in vivo and in vitro experiments, respectively, with appropriate antibiotics (100 µg/ml ampicillin, 34 µg/ml chloramphenicol, 50 µg/ml kanamycin Wild-type yeast, Saccharomyces cerevisiae strain YPH499, were cultured in standard YPD (1% yeast extract, 2% peptone, 2% glucose) at 30°C. Yeast mutants were cultured in synthetic complete growth media lacking uracil and supplemented with 2% glucose at 30℃. For liquid cultures, media was further supplemented with 0.0025% penicillin and 0.0025% streptomycin. Competent cells were prepared as previously described 35 and transformed by the LiAc/PEG method. Briefly, competent cells were rinsed in water and incubated in transformation mix containing 0.5 μg DNA, 3 μg/mL salmon sperm DNA (Sigma-Aldrich, UK), 100 mM LiAc, 10 mM Tris pH 7.5, 1 mM EDTA and 40% PEG 3000, for 30 min at 30°C followed by 15min at 42°C.
Cells were let to recover in YPD for 60 min at 30°C before plating on synthetic growth media lacking uracil (Kaiser mixture; Formedium, UK) and supplemented with 2% glucose.
Cloning
mt-11S for mitochondrial preparations
To produce yeast expressing 11S in the mitochondrial matrix, the 11S amino acid sequence previously 
GST-dark peptide for in-vitro experiments
To allow recombinant expression and purification of large quantities of dark peptide, we fused it to the Cterminus of glutathione-S-transferase (GST). This was done by PCR insertion of a DNA sequence coding for a pep86 version that does not luminesce (dark peptide, see details in 13 ) immediately after the BamHI site in pGEX-1 (primer sequences:
CATCCTCCAAAATCGGATCCCGGAGTGAGCGGCTGGGCGCTGTTTAAAAAAATTAGCTAAGAAT TCATCGTGACTGAC and GTCAGTCACGATGAATTCTTAGCTAATTTTTTTAAACAGCGCCCAGCCGCTCACTCCGGGATCCG ATTTTGGAGGATG). The resulting plasmid (pGEX-GST-dark) was verified by DNA sequencing, then transformed into BL21 (DE3) cells.
proOmpA (±pep86) proOmpA with a C-terminal minimal V5 epitope was produced as described previously 2 . For the real-time translocation assays, PCR insertion was used to add the pep86 sequence, preceded by a short GSG linker, after the V5 tag (primers:
GAATCCGCTGCTGGGCCTGGGCTCCGGCGTGAGCGGCTGGCGCCTGTTTAAAAAAATTAGCTAA GCTTACGTAGAACAAAAAC and GTTTTTGTTCTACGTAAGCTTAGCTAATTTTTTTAAACAGGCGCCAGCCGCTCACGCCGGAGCCC AGGCCCAGCAGCGGATTC). After verifying the clone by DNA sequencing, proOmpA-pep86 was expressed and purified using exactly the same protocol as standard proOmpA.
proSpy(±pep86) and mSpy(±pep86)
To produce the periplasmic chaperone proSpy (EG13490), an E. coli optimised gene string (Life Technologies) for proSpy with a C-terminal minimal V5 epitope, a linker with pep86 tag, a TEV cleavage sequence and a 6-his tag was cloned into pBAD-HisA using overlap extension mutagenesis. For the mature form of Spy, a separate gene string was purchased omitting the signal sequence (1-23 aa). The resulting plasmids, pBAD-proSpy-pep86 and pBAD-mSpy-pep86, were verified by DNA sequencing, then transformed into MM52 and BL21(DE3), respectively.
CytB2±pep86 and
Δ mts-CytB2-pep86
An engineered version of yeast cytochrome B2 (YML054C, 18 ) comprising the first 158 aa with its hydrophobic domain on the signal sequence deleted (Δ43-65) followed by two tandem TEV cleave sites, a
Myc tag and a C-term 6xhis tag, was codon-optimised for E. coli and purchased as a gene on plasmid (Eurofins, Germany). Then, the plasmid was digested with NcoI and HindIII, and the insert ligated into the corresponding sites of pBAD/Myc-His C (yielding pBAD--CytB2 GAACCGAAACTCGACATGAACAAA and CATGGTTAATTCCTCCTGTTAGCC for pBAD--
. All plasmids were verified by sequencing then transformed into BL21(DE3) cells.
pro11S--GST-dark for in-vivo experiments
To produce bacteria expressing 11S in the periplasm, the amino acid sequence of 11S was codon-optimised 
Proteoliposome (PL) preparation
SecYEG proteoliposomes were produced as described previously 3 . Briefly, purified SecYEG was mixed with E. coli polar lipids in DDM, then the detergent removed gradually using BioBeads. To encapsulate 11S, we simply included purified 11S at the desired final concentration (20 µM standard, or as noted in the text) in the SecYEG/polar lipid mix, prior to the addition of biobeads. For the initial experiments, SecYEG/11S PLs were harvested by centrifugation (30 mins at 100,000 g) as per the standard method, washed twice by resuspending in 3 mL TKM then centrifuging for 30 min at 100,000 g and pipetting off the supernatant, then resuspended to give the desired final SecYEG concentration. These additional washing steps removed most of the nonencapsulated 11S, reducing the background signal for the transport assays -although they did not obviate the need for GST-dark. For the 11S concentration series we instead passed the reconstituted PLs over a gravity flow Sephacryl-S1000 column to separate away unbound 11S. These PLs were quantified by scattering at 320 nm (relative to PLs produced using the standard method), then used directly in transport assays. This method 1 is both more effective at removing free 11S and eliminates the centrifugation and resuspension steps, which potentially damage PLs and cause them to leak.
IMV preparation
IMVs were either prepared from E. coli BL21 (DE3) or a strain lacking ATP synthase (unc -; HB1 cells 36 ), to prevent PMF generation upon addition of ATP. Cells were grown to mid-log phase and 37 ˚C in 2xYT
supplemented with 100 μg/mL ampicillin and 50 μg/L kanamycin, then co-induced for 2½ h with 0.1% arabinose and 1 mM IPTG. Inverted membrane vesicles were prepared from the membranes as described previously 2 .
Mitochondrial isolation
mt-11S-expressing yeast were grown overnight at 30℃ in synthetic growth media lacking uracil and supplemented with 3% glycerol plus 0.0025% Pen/Strep. Yeast cells were cultured in glycerol-based media to increase mitochondrial mass and maximise mitochondrial function 19 . 1% galactose was added at mid-log phase to start inducing mt-11S (total time ~16h). In the end, mitochondria were isolated through differential centrifugation after cell wall was reduced by 1 mM DTT in 100 mM Tris-SO 4 buffer for 15 min at 30℃ and then digested with zymolase in sorbitol-phosphate buffer for 30 min at 30℃. The final mitochondrial pellet was resuspended in 250 mM sucrose and 10 mM MOPS, pH 7.2. Mitochondrial protein was quantified by BCA assay, using BSA as standard.
Binding experiments
Complementation of pep86-tagged precursor with pure 6H 11S was performed in 1x Nano-Glo buffer diluted with TK buffer and Prionex (0.1% final). The reaction mix containing 1x furimazine was used to prepare a titration curve of precursor ranging from 13.9 nM to 3 µM which was added to a 96-well plate. Separately, pure 11S was diluted in reaction mix supplemented with 1x furimazine so that automatic injection of 80 µ L would give the desired concentration upon addition (30 pM in 100 µL). Luminescence was read on BioTek 
Western blot transport assays
For the The background, caused by association of proOmpA-pep86 with non-encapsulated 11S, fits well to a single (PLs) or double (IMVs) exponential (Fig. 2) . Therefore, we fitted the signal from after proOmpA-pep86 but prior to ATP addition to a single exponential, and subtracted the resulting fit from the raw data. This corrected data corresponds to ATP-driven protein transport.
Microplate mode
For the Synergy Neo2 plate reader (BioTek Instruments, UK) was used instead, additions were made automatically using the system pump set to the default injection speed followed by a 5 sec linear shaking step. In both plate readers, luminescence was collected for 0.2 sec/well, without emission filters, and the gain was set to allow maximum sensitivity without detector saturation. An initial baseline of 60 sec was acquired before precursor addition and then luminescence was read for at least 20 min. Time between reads was set to the minimum allowed interval in each plate reader -10-12 sec for LumiCount and 5 sec for Neo2.
In-vivo β-lactamase secretion assay
E. coli MC4100 were transformed with pBAD-pro11S--GST-dark alone or in combination with pSU2718-- 
Data analysis and Statistics
Results are shown as means ± SEM of the indicated number of experiments. Apparent rates (k app ) were calculated as the reciprocal of the time it takes to reach half of the maximal luminescent signal (t 50% ).
Statistical significance between mean differences was determined using two-tailed Student's t test or one-way ANOVA, when more than two groups were analysed, followed by predefined contrasts using Bonferoni's post-hoc analysis to correct for multiple comparisons. Differences were considered significant if p < 0.05 and categorized accordingly to their interval of confidence. Statistical analyses were performed using Graph Pad Prism version 8.0.0 (GraphPad Software, Inc., San Diego, CA, USA). and is shown as mean ± SEM. Differences between groups were analysed by a one-way ANOVA with predefined contrasts corrected with Holm-Sidak test. ***, p < 0.001; **, p< 0.01; ns, not significant.
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